HN3, a fully human heavy chain variable region (VH) domain antibody, targets the N-lobe of GPC3 and is able to block Wnt signaling to inhibit HCC cell proliferation 12, 13. The gene discussed is GPC3; the disease is hepatocellular carcinoma.